High NOS2/COX2-expressing tumors exhibited increased IDO1 clustering that was more closely associated with tumor margins proximal to elevated NOS2Tumor regions (Figure 8A), while low expression was observed in immune desert regions in deceased patient tumors (Figure 8B). This evidence concerns the gene IDO1 and neoplasm.